Today’s issue of WorkCompRecap features the release of a new report from WCRI that examined the use of injectable therapies play a key role in workers’ comp, including utilization, costs, key cost drivers, and recent trends across 28 states through early 2024.

The newly-released WCRI study is Injectable Therapies in Workers’ Compensation.  You can find more information, including details on how to download a copy, elsewhere on our website; we also have a video about the study!